First Time Loading...

Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 14 700 JPY 0.93% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one Cosmos Pharmaceutical Corp stock under the Base Case scenario is 15 988.72 JPY. Compared to the current market price of 14 700 JPY, Cosmos Pharmaceutical Corp is Undervalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
15 988.72 JPY
Undervaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
79
vs Industry
39
Median 3Y
0.7
Median 5Y
0.7
Industry
0.6
Forward
0.6
More Details
24.2
P/E
P/E
Price to Earnings
24.2
vs History
49
vs Industry
19
Median 3Y
24.2
Median 5Y
24.2
Industry
16.4
Forward
23.1
More Details
10.7
P/OCF
P/OCF
Price to OCF
10.7
vs History
84
vs Industry
26
Median 3Y
13.1
Median 5Y
12.1
Industry
8
More Details
90.3
P/FCFE
P/FCFE
Price to FCFE
90.3
vs History
14
vs Industry
5
Median 3Y
-40.2
Median 5Y
20.9
Industry
15.7
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
84
vs Industry
25
Median 3Y
2.9
Median 5Y
3.2
Industry
1.6
More Details
0.6
EV/S
EV/S
Enterprise Value to Sales
0.6
vs History
77
vs Industry
44
Median 3Y
0.7
Median 5Y
0.7
Industry
0.7
Forward
0.6
More Details
3.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.1
vs History
74
vs Industry
30
Median 3Y
3.4
Median 5Y
3.4
Industry
2.2
More Details
11.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.4
vs History
58
vs Industry
23
Median 3Y
11.9
Median 5Y
11.9
Industry
8.4
Forward
11.1
More Details
18.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.4
vs History
39
vs Industry
20
Median 3Y
18.1
Median 5Y
17.8
Industry
12.7
Forward
15.9
More Details
10.3
EV/OCF
EV/OCF
Enterprise Value to OCF
10.3
vs History
84
vs Industry
31
Median 3Y
12.5
Median 5Y
11.7
Industry
9.1
More Details
824.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
824.5
vs History
4
vs Industry
0
Median 3Y
21.7
Median 5Y
40.3
Industry
12.6
More Details
2.3
EV/IC
EV/IC
Enterprise Value to IC
2.3
vs History
87
vs Industry
18
Median 3Y
2.7
Median 5Y
2.8
Industry
1.1
More Details

Multiples Across Competitors

Competitors Multiples
Cosmos Pharmaceutical Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Cosmos Pharmaceutical Corp
TSE:3349
582.5B JPY 0.6 24.2 11.4 18.4
ZA
Clicks Group Ltd
JSE:CLS
72.8B Zac 0 0 0 0
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
28.4B Zac 0 0 0 0
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
15.4B USD 0.1 -2.5 5.3 11.8
BR
Raia Drogasil SA
BOVESPA:RADL3
45B BRL 1.3 42.6 12.9 23.1
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
44.2B CNY 2 30.7 21.5 21.5
JP
MatsukiyoCocokara & Co
TSE:3088
927.9B JPY 0.9 18.3 9.1 11.7
SA
Al Nahdi Medical Company SCJSC
SAU:4164
17.9B SAR 2.1 20.1 11.3 18.6
MX
Corporativo Fragua SAB de CV
BMV:FRAGUAB
77.1B MXN 0.7 17.1 7.8 9.2
JP
Sundrug Co Ltd
TSE:9989
526.2B JPY 0.7 18.7 8.4 11.1
CN
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
24.7B CNY 1 19.2 14.7 14.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.